Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Debt to Equity (2019)

Historic Debt to Equity for Avidity Biosciences (RNA) over the last 1 years, with Q4 2019 value amounting to -$0.07.

  • Avidity Biosciences' Debt to Equity changed N/A to -$0.07 in Q4 2019 from the same period last year, while for Dec 2019 it was -$0.07, marking a year-over-year change of. This contributed to the annual value of -$0.07 for FY2019, which is N/A changed from last year.
  • Per Avidity Biosciences' latest filing, its Debt to Equity stood at -$0.07 for Q4 2019.
  • Over the past 5 years, Avidity Biosciences' Debt to Equity peaked at -$0.07 during Q4 2019, and registered a low of -$0.07 during Q4 2019.